Matsui T - Search Results

1

Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.

Takamiya Y, Fukami K, Yamagishi S, Kaida Y, Nakayama Y, Obara N, Iwatani R, Ando R, Koike K, Matsui T, Nishino Y, Ueda S, Cooper ME, Okuda S. Takamiya Y, et al. Among authors: matsui t. Nephrol Dial Transplant. 2013 Jan;28(1):55-62. doi: 10.1093/ndt/gfs387. Epub 2012 Sep 30. Nephrol Dial Transplant. 2013. PMID: 23028104

2

Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B.

Yamagishi S, Nakamura K, Takenaka K, Matsui T, Jinnouchi Y, Imaizumi T. Yamagishi S, et al. Among authors: matsui t. Microvasc Res. 2005 May;69(3):128-34. doi: 10.1016/j.mvr.2005.04.001. Microvasc Res. 2005. PMID: 15896354

3

Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.

Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T. Takenaka K, et al. Among authors: matsui t. Life Sci. 2005 Nov 4;77(25):3231-41. doi: 10.1016/j.lfs.2005.05.048. Epub 2005 Jun 27. Life Sci. 2005. PMID: 15985268

4

Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression.

Yamagishi S, Takeuchi M, Matsui T, Nakamura K, Imaizumi T, Inoue H. Yamagishi S, et al. Among authors: matsui t. FEBS Lett. 2005 Aug 15;579(20):4265-70. doi: 10.1016/j.febslet.2005.06.058. FEBS Lett. 2005. PMID: 16051229 Free article.

5

Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.

Nakamura K, Yamagishi S, Nakamura Y, Takenaka K, Matsui T, Jinnouchi Y, Imaizumi T. Nakamura K, et al. Among authors: matsui t. Microvasc Res. 2005 Nov;70(3):137-41. doi: 10.1016/j.mvr.2005.10.002. Microvasc Res. 2005. PMID: 16271939

6

Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes.

Takenaka K, Yamagishi S, Matsui T, Nakamura K, Imaizumi T. Takenaka K, et al. Among authors: matsui t. Curr Neurovasc Res. 2006 Feb;3(1):73-7. doi: 10.2174/156720206775541804. Curr Neurovasc Res. 2006. PMID: 16472128 Review.

7

Cardiovascular disease in diabetes.

Yamagishi S, Nakamura K, Matsui T, Takenaka K, Jinnouchi Y, Imaizumi T. Yamagishi S, et al. Among authors: matsui t. Mini Rev Med Chem. 2006 Mar;6(3):313-8. doi: 10.2174/138955706776073501. Mini Rev Med Chem. 2006. PMID: 16515470 Review.

8

Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.

Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M, Furuki K, Hino A, Jinnouchi Y, Takenaka K, Matsui T, Nakamura K, Imaizumi T. Yamagishi S, et al. Among authors: matsui t. J Clin Endocrinol Metab. 2006 Jun;91(6):2447-50. doi: 10.1210/jc.2005-2654. Epub 2006 Mar 7. J Clin Endocrinol Metab. 2006. PMID: 16522692

9

Pleiotropic effects of nifedipine on atherosclerosis.

Yamagishi S, Nakamura K, Takenaka K, Matsui T, Inoue H. Yamagishi S, et al. Among authors: matsui t. Curr Pharm Des. 2006;12(12):1543-7. doi: 10.2174/138161206776389877. Curr Pharm Des. 2006. PMID: 16611134 Review.

10

Atorvastatin and diabetic vascular complications.

Yamagishi S, Matsui T, Nakamura K. Yamagishi S, et al. Among authors: matsui t. Curr Pharm Des. 2006;12(12):1549-54. doi: 10.2174/138161206776389796. Curr Pharm Des. 2006. PMID: 16611135 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,284 results

Search Page

Filters